The Next Big Player in Healthcare Tech

Robotics and automation have been rocking the healthcare industry and changing the way many healthcare companies operate. These technologies have helped medical companies cut costs, reduce errors, and focus their efforts on higher-end activities.

Many healthcare tech stocks like these could be poised to skyrocket soon, as these companies will likely be committed to investing in robotics and automation to improve their financial performance.

Stocks in this space appear to have bottomed out and are likely in the early phases of a new bull run, which may trounce the previous bull market of the early 2020s. Companies with minute $1-5 billion market caps are already disrupting this industry, serving some of the top healthcare companies.

One key strategic area for companies to target is pharmacy automation, as it can help companies boost revenue, reduce errors, and lower operating costs. Most importantly, it can help these companies automate lower-end tasks, such as packaging and distribution, and allow their staff to focus on higher-end activities such as analytics and patient care. Pharmaceutical companies have been investing heavily in this area and will likely continue to do so to stay ahead of the curve.

This report will cover a pharmaceutical automation giant that has contracts with nearly half of the leading US healthcare companies. Shares have begun to soar in the past few weeks on the back of solid earnings results, but there is still likely a lot more room for this company’s share price to run.

This company helps healthcare companies implement robotics and automation to improve their pharmacy services and it has a strong benchmark of success with healthcare giants in the United States. This company has a multi-decade track record of success and is potentially poised for massive success in 2025 as industry dynamics potentially take a better turn. Most of its business segments have strong double-digit growth potential in the coming years, and it has consistently been investing in new sources of growth.

Spending on automation and robotics may become much more common for healthcare companies in the future, and existing case studies have shown that this expenditure is necessary for companies that want to cut costs and improve their operations. Growth in this area will likely continue to be healthy in 2024 and stronger in 2025. Companies in this area appear positioned to soar this year as it has been consistently investing in new offerings through acquisitions and new product launches.

Despite this company’s multi-decade track record, strong growth prospects, and new developments, this company still sits on a tiny market cap of around $2 billion. H2 2024 looks like the perfect time to gain exposure to this company, as its stock has bottomed out and appears to be in the early stages of a bull run. Moreover, this company has been investing heavily during some of the relatively slower periods, which could allow it to trounce competitors as growth comes back online.

Read more to learn about this company’s history, recent investments, and future growth prospects!

Subscribe to Elite Trade Club Insider to read the rest.